HR 6988 United States House · 117th Congress

Drug Manufacturing Innovation Act of 2022

Summary
Drug Manufacturing Innovation Act of 2022 This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 8, 2022 Last action Mar 9, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Mar 9, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 8, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 8, 2022
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors